2026 #NLASessions Expert Theater Lineup

 

Expert Theaters are industry supported, non CME educational sessions held during designated breaks in the official meeting schedule. These focused programs feature thought leaders and clinical experts who dive into timely topics in lipid management, cardiovascular risk reduction, and emerging therapies.

Attendance is open to all registered meeting participants and food and beverages (provided by the NLA) are offered at every Expert Theater.

 

 Thursday, June 11 | 3:00-3:50pm CT

  Break food and beverage provided by the NLA

Session Title Coming Soon

Sheraton Ballroom 3 | Sponsored by Chiesi Global Rare Disease

Redefining Risk: Leveraging CCTA and Plaque Analysis for Personalized Cardiovascular Prevention

Sheraton Ballroom 2 | Sponsored by Heartflow

This Expert Theater will cover the use of CCTA and Heartflow Plaque Analysis for precise cardiovascular risk stratification, focusing on identifying patient populations, providing practical insights into clinical integration, and exploring the future of plaque-focused prevention strategies.


Speakers

Nihar R. Desai, MD, MPH
Associate Professor of Medicine
Yale School of Medicine
Vice Chief, Section of Cardiovascular Medicine
Investigator, Center for Outcomes Research and Evaluation
New Haven, CT

Sarah Rinehart, MD, FACC, FSCC
Medical Director Cardiac Imaging Center
CV CT, Lipid/Prevention Clinic
Charleston Area Medical Center
Charleston, WV

 

 Friday, June 12 | 12:25-1:15pm CT

  Lunch provided by the NLA

Session Title Coming Soon

Sheraton Ballroom 2 | Sponsored by Ionis Pharmaceuticals

Session Title Coming Soon

Sheraton Ballroom 3 | Sponsored by Kaneka - LIPOSORBER

 

 Saturday, June 13 | 8:00-8:50am CT

  Breakfast provided by the NLA

Session Title Coming Soon

Sheraton Ballroom 2 | Sponsored by Arrowhead Pharmaceuticals, Inc.

Uncover HoFH, an ultra-rare lipid disorder, and Explore EVKEEZA (evinacumab-dgnb) as a treatment option

Sheraton Ballroom 3 | Sponsored by Regeneron

This Expert Theater will cover the use of CCTA and Heartflow Plaque Analysis for precise cardiovascular risk stratification, focusing on identifying patient populations, providing practical insights into clinical integration, and exploring the future of plaque-focused prevention strategies.


Speaker

Alan S. Brown, MD, MPH, MNLA

 

 Saturday, June 13 | 12:35-1:25pm CT

  Lunch provided by the NLA

Session Title Coming Soon

Sheraton Ballroom 3 | Sponsored by Amgen

Session Title Coming Soon

Sheraton Ballroom 2 | Sponsored by Ionis Pharmaceuticals